Quantitative structure−activity relationship modeling is one of the major computational tools employed in medicinal chemistry. However, throughout its entire history it has drawn both praise and criticism concerning its reliability, limitations, successes, and failures. In this paper, we discuss (i) the development and evolution of QSAR; (ii) the current trends, unsolved problems, and pressing challenges; and (iii) several novel and emerging applications of QSAR modeling. Throughout this discussion, we provide guidelines for QSAR development, validation, and application, which are summarized in best practices for building rigorously validated and externally predictive QSAR models. We hope that this Perspective will help communications between computational and experimental chemists toward collaborative development and use of QSAR models. We also believe that the guidelines presented here will help journal editors and reviewers apply more stringent scientific standards to manuscripts reporting new QSAR studies, as well as encourage the use of high quality, validated QSARs for regulatory decision making.

QSAR Modeling: Where Have You Been? Where Are You Going To?

GRAMATICA, PAOLA;
2014-01-01

Abstract

Quantitative structure−activity relationship modeling is one of the major computational tools employed in medicinal chemistry. However, throughout its entire history it has drawn both praise and criticism concerning its reliability, limitations, successes, and failures. In this paper, we discuss (i) the development and evolution of QSAR; (ii) the current trends, unsolved problems, and pressing challenges; and (iii) several novel and emerging applications of QSAR modeling. Throughout this discussion, we provide guidelines for QSAR development, validation, and application, which are summarized in best practices for building rigorously validated and externally predictive QSAR models. We hope that this Perspective will help communications between computational and experimental chemists toward collaborative development and use of QSAR models. We also believe that the guidelines presented here will help journal editors and reviewers apply more stringent scientific standards to manuscripts reporting new QSAR studies, as well as encourage the use of high quality, validated QSARs for regulatory decision making.
2014
http://pubs.acs.org/jmc
Antimicrobial Cationic Peptides; Artificial Intelligence; Complex Mixtures; Databases, Factual; History, 20th Century; History, 21st Century; Nanostructures; Pharmacokinetics; Quantum Theory; Toxicology; Drug Design; Models, Molecular; Quantitative Structure-Activity Relationship; Molecular Medicine; Drug Discovery3003 Pharmaceutical Science
A, Cherkasov; E. N., Muratov; D, Fourches; A, Varnek; I. I., Baskin; M., Cronin; J., Dearden; Gramatica, Paola; Y. C., Martin; R, Todeschini; V, Consonni; V. E., Kuz’Min; R., Cramer; R., Benigni; C., Yang; J., Rathman; L., Terfloth; J., Gasteiger; A., Richard; A, Tropsha
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1872121
Citazioni
  • ???jsp.display-item.citation.pmc??? 347
  • Scopus 1333
  • ???jsp.display-item.citation.isi??? 1185
social impact